Cognex (NASDAQ:CGNX) Sets New 1-Year High - Here's Why

Key Points

• Cognex shares hit a new 52-week high, trading as high as $72.35 after closing at $68.36 the prior day. The move came on heavy volume of 1.81 million shares.
• Recent earnings were strong, with Cognex reporting $0.34 EPS versus the $0.25 consensus and revenue of $268.44 million, up 24.3% year over year. The company also guided Q2 2026 EPS to $0.40-$0.44.
• Wall Street sentiment remains broadly positive, with multiple firms raising or reaffirming targets around $68-$75 and the stock carrying a consensus rating of Moderate Buy. Institutional ownership is also high at 88.12%, even as several insiders sold shares recently.

Cognex Corporation (NASDAQ:CGNX - Get Free Report) shares reached a new 52-week high during trading on Tuesday . The company traded as high as $72.35 and last traded at $71.5410, with a volume of 1811368 shares. The stock had previously closed at $68.36.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on the company. Sanford C. Bernstein restated an "outperform" rating and issued a $75.00 price target on shares of Cognex in a research report on Thursday, May 7th. Citigroup reissued a "neutral" rating and issued a $68.00 price objective (up from $60.00) on shares of Cognex in a research note on Friday, May 8th. UBS Group set a $75.00 target price on shares of Cognex in a report on Tuesday, May 26th. Truist Financial set a $61.00 target price on shares of Cognex and gave the stock a "hold" rating in a research report on Friday, May 8th. Finally, Barclays reaffirmed an "overweight" rating and issued a $75.00 price target (up from $64.00) on shares of Cognex in a report on Monday, May 11th. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat, Cognex currently has an average rating of "Moderate Buy" and a consensus target price of $70.43.

Cognex Stock Up 5.1%

The firm has a market cap of $11.95 billion, a price-to-earnings ratio of 85.60 and a beta of 1.52. The business has a 50 day moving average of $62.59 and a 200 day moving average of $51.58.

Cognex (NASDAQ:CGNX - Get Free Report) last released its earnings results on Wednesday, May 6th. The scientific and technical instruments company reported $0.34 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.25 by $0.09. The company had revenue of $268.44 million for the quarter, compared to analyst estimates of $245.98 million. Cognex had a net margin of 13.62% and a return on equity of 10.89%. The firm's quarterly revenue was up 24.3% on a year-over-year basis. During the same period in the prior year, the firm earned $0.14 EPS. Cognex has set its Q2 2026 guidance at 0.400-0.440 EPS. Research analysts predict that Cognex Corporation will post 1.49 earnings per share for the current year.

Cognex Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, June 4th. Shareholders of record on Thursday, May 21st were issued a $0.085 dividend. The ex-dividend date was Thursday, May 21st. This represents a $0.34 annualized dividend and a yield of 0.5%. Cognex's payout ratio is 40.48%.

Insiders Place Their Bets

In other Cognex news, VP Laura Ann Macdonald sold 98,122 shares of the stock in a transaction on Monday, May 11th. The stock was sold at an average price of $66.80, for a total transaction of $6,554,549.60. Following the transaction, the vice president owned 5,258 shares of the company's stock, valued at $351,234.40. This represents a 94.91% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, VP Darren Marc Long sold 20,252 shares of the firm's stock in a transaction on Wednesday, May 27th. The stock was sold at an average price of $66.34, for a total value of $1,343,517.68. Following the sale, the vice president owned 3,990 shares in the company, valued at $264,696.60. This trade represents a 83.54% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 224,847 shares of company stock valued at $14,975,098 in the last quarter. 1.70% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of CGNX. Royal Bank of Canada boosted its position in shares of Cognex by 13.2% in the first quarter. Royal Bank of Canada now owns 200,351 shares of the scientific and technical instruments company's stock worth $5,976,000 after acquiring an additional 23,326 shares during the last quarter. Empowered Funds LLC acquired a new position in Cognex during the first quarter worth approximately $291,000. Intech Investment Management LLC raised its stake in Cognex by 24.1% during the first quarter. Intech Investment Management LLC now owns 47,444 shares of the scientific and technical instruments company's stock worth $1,415,000 after purchasing an additional 9,223 shares during the period. Geneos Wealth Management Inc. raised its stake in Cognex by 402.2% during the first quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company's stock worth $27,000 after purchasing an additional 736 shares during the period. Finally, Cetera Investment Advisers boosted its holdings in shares of Cognex by 7.5% in the 2nd quarter. Cetera Investment Advisers now owns 13,208 shares of the scientific and technical instruments company's stock valued at $419,000 after purchasing an additional 920 shares during the last quarter. Institutional investors and hedge funds own 88.12% of the company's stock.

About Cognex

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company's product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.